Dwayne Conway

2.5k total citations
27 papers, 1.3k citations indexed

About

Dwayne Conway is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology. According to data from OpenAlex, Dwayne Conway has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 12 papers in Internal Medicine and 5 papers in Epidemiology. Recurrent topics in Dwayne Conway's work include Atrial Fibrillation Management and Outcomes (14 papers), Venous Thromboembolism Diagnosis and Management (12 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Dwayne Conway is often cited by papers focused on Atrial Fibrillation Management and Outcomes (14 papers), Venous Thromboembolism Diagnosis and Management (12 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Dwayne Conway collaborates with scholars based in United Kingdom, Australia and Netherlands. Dwayne Conway's co-authors include Gregory Y.H. Lip, Elizabeth Hughes, B Chin, Robert G. Hart, Lesly A. Pearce, N. Chung, Andrew D. Blann, Jacqueline C.M. Witteman, Deirdre A.M. van der Kuip and Albert Hofman and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Stroke.

In The Last Decade

Dwayne Conway

26 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dwayne Conway United Kingdom 14 1.0k 394 183 130 125 27 1.3k
Daniel J. Crusan United States 20 508 0.5× 272 0.7× 70 0.4× 77 0.6× 211 1.7× 29 910
Steven P. Ball United States 16 572 0.6× 252 0.6× 67 0.4× 113 0.9× 304 2.4× 27 814
Samer Kabbani United States 15 494 0.5× 125 0.3× 61 0.3× 101 0.8× 262 2.1× 26 654
P Stevens Canada 14 259 0.3× 386 1.0× 77 0.4× 379 2.9× 261 2.1× 21 955
Charalambos Vlachopoulos Greece 8 238 0.2× 249 0.6× 63 0.3× 44 0.3× 321 2.6× 10 637
Serdar Sevimli Türkiye 19 678 0.7× 84 0.2× 155 0.8× 33 0.3× 254 2.0× 88 969
Marc Cairols Spain 17 281 0.3× 198 0.5× 119 0.7× 45 0.3× 379 3.0× 37 760
Marie‐Antoinette Sevestre France 18 335 0.3× 512 1.3× 45 0.2× 70 0.5× 370 3.0× 52 842
Özgür Sürgit Türkiye 18 423 0.4× 76 0.2× 129 0.7× 26 0.2× 138 1.1× 49 705
Arzu Kalaycı Türkiye 14 415 0.4× 107 0.3× 132 0.7× 19 0.1× 179 1.4× 73 684

Countries citing papers authored by Dwayne Conway

Since Specialization
Citations

This map shows the geographic impact of Dwayne Conway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dwayne Conway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dwayne Conway more than expected).

Fields of papers citing papers by Dwayne Conway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dwayne Conway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dwayne Conway. The network helps show where Dwayne Conway may publish in the future.

Co-authorship network of co-authors of Dwayne Conway

This figure shows the co-authorship network connecting the top 25 collaborators of Dwayne Conway. A scholar is included among the top collaborators of Dwayne Conway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dwayne Conway. Dwayne Conway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conway, Dwayne, Javaid Iqbal, Arvindra Krishnamurthy, et al.. (2024). Duration of triple antithrombotic therapy and clinical outcomes after percutaneous coronary intervention in atrial fibrillation. Expert Review of Cardiovascular Therapy. 22(7). 339–345. 1 indexed citations
2.
Nelson, Thomas A., J. David Richardson, Arvindra Krishnamurthy, et al.. (2023). 71 Initial clinical experience with 6-hour enoxaparin regimen in opiate-treated patients undergoing primary percutaneous coronary intervention. A81.1–A81. 1 indexed citations
3.
Harris, Emma, Alex Benham, John Stephenson, et al.. (2023). Patient decision aids for aortic stenosis and chronic coronary artery disease: a systematic review and meta-analysis. European Journal of Cardiovascular Nursing. 23(6). 561–581. 2 indexed citations
4.
Harris, Emma, et al.. (2022). Development and user-testing of a digital patient decision aid to facilitate shared decision-making for people with stable angina. BMC Medical Informatics and Decision Making. 22(1). 143–143. 5 indexed citations
6.
Heeringa, Jan, Dwayne Conway, Deirdre A.M. van der Kuip, et al.. (2006). A longitudinal population‐based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990–1999. Journal of Thrombosis and Haemostasis. 4(9). 1944–1949. 53 indexed citations
7.
Conway, Dwayne & Gregory Y.H. Lip. (2004). Comparison of outcomes of patients with symptomatic peripheral artery disease with and without atrial fibrillation (the West Birmingham Atrial Fibrillation Project). The American Journal of Cardiology. 93(11). 1422–1425. 52 indexed citations
8.
Conway, Dwayne, et al.. (2004). Relationship of interleukin-6 and C-Reactive protein to the prothrombotic state in chronic atrial fibrillation. Journal of the American College of Cardiology. 43(11). 2075–2082. 214 indexed citations
9.
Conway, Dwayne, et al.. (2004). Relation of interleukin-6, C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillation. The American Journal of Cardiology. 93(11). 1368–1373. 56 indexed citations
10.
Conway, Dwayne, et al.. (2004). Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. American Heart Journal. 148(3). 462–466. 161 indexed citations
11.
Conway, Dwayne, et al.. (2004). Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation. The American Journal of Cardiology. 94(4). 508–510. 62 indexed citations
12.
Harten, J., B. McCreath, John Kinsella, et al.. (2003). Oxygen delivery failure. Anaesthesia. 58(2). 190–191.
13.
Harten, J., B. McCreath, John Kinsella, et al.. (2003). Making herbal medicines safe. Anaesthesia. 58(2). 184–185. 1 indexed citations
14.
Conway, Dwayne, et al.. (2003). Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure. Blood Coagulation & Fibrinolysis. 14(6). 515–521. 61 indexed citations
15.
Conway, Dwayne & Gregory Y.H. Lip. (2003). Ethnicity in relation to atrial fibrillation and stroke (the West Birmingham Stroke Project). The American Journal of Cardiology. 92(12). 1476–1479. 34 indexed citations
16.
Conway, Dwayne, Jan Heeringa, Deirdre A.M. van der Kuip, et al.. (2003). Atrial Fibrillation and the Prothrombotic State in the Elderly. Stroke. 34(2). 413–417. 72 indexed citations
17.
Chung, N., F. Belgore, Foo Leong Li‐Saw‐Hee, et al.. (2002). Is the Hypercoagulable State in Atrial Fibrillation Mediated by Vascular Endothelial Growth Factor?. Stroke. 33(9). 2187–2191. 59 indexed citations
18.
Conway, Dwayne, Lesly A. Pearce, B Chin, Robert G. Hart, & Gregory Y.H. Lip. (2002). Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 1321 Patients With Nonvalvular Atrial Fibrillation. Circulation. 106(15). 1962–1967. 158 indexed citations
19.
20.
Conway, Dwayne, et al.. (2000). Atopic eczema and staphylococcal endocarditis: time to recognize an association?. Hospital Medicine. 61(5). 356–357. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026